Latest News and Press Releases

ALBANY, N.Y., March 19, 2026 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK...

PharmAla completes delivery of a Phase 3 clinical trial contract after finishing release testing on an australian-made batch of LaNeo MDMA.

Curia's sterile drug product in Burlington, MA, was named “Manufacturer of the Year” by the Massachusetts Legislative Manufacturing Caucus.

HUNTSVILLE, AL, May 14, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for...

BUBENDORF, Schweiz, March 24, 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS med hjemsted i Schweiz, en førende virksomhed inden for udvikling af farmaceutiske processer og fremstilling af aktive...

BUBENDORF, Schweiz, March 24, 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS mit Sitz in der Schweiz, ein führendes Unternehmen für pharmazeutische Prozessentwicklung und Wirkstoffherstellung (API), freut...

BUBENDORF, Suisse, 24 mars 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS, société suisse leader dans le développement de procédés pharmaceutiques et la fabrication d’ingrédients pharmaceutiques actifs...

CARBOGEN AMCIS has been granted a GMP certificate for the Saint-Beauzire facility, marking a significant milestone in the site's successful start-up.

ニューヨーク州オールバニ発 , March 17, 2025 (GLOBE NEWSWIRE) -- 研究開発・製造業務受託機関のリーダーであるキュリア・グローバル (Curia Global, Inc.)(キュリア) は本日、英国グラスゴー施設の拡張計画を発表し、ニューメキシコ州アルバカーキで進行中の拡張プロジェクトの最新情報を提供した。 ...

奧爾巴尼，紐約州, March 17, 2025 (GLOBE NEWSWIRE) -- 頂尖的合約研究、開發及製造企業 Curia Global, Inc. (Curia) 今天宣佈擴展其英國格拉斯哥工廠的計劃，並就新墨西哥州阿爾伯克基進行中的擴張計劃披露最新進展。 Curia...